Transatlantic collaboration in pediatric oncology: Now is the time

Journal of Pediatric Hematology/Oncology

Volumn 26, Issue 12, 2004, Pages 783-784

  Hawkins, Douglas S ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; MYELOABLATIVE AGENT;

ACUTE LYMPHOBLASTIC LEUKEMIA; CANCER CHEMOTHERAPY; CANCER INCIDENCE; CANCER RADIOTHERAPY; CHILDHOOD CANCER; CLINICAL STUDY; CLINICAL TRIAL; EDITORIAL; HEMATOLOGIC MALIGNANCY; HUMAN; INTERNATIONAL COOPERATION; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; RHABDOMYOSARCOMA;

CHILD; EUROPE; HUMANS; INTERNATIONAL COOPERATION; MEDICAL ONCOLOGY; NEOPLASMS; PEDIATRICS; UNITED STATES;

EID: 10944255774     PISSN: 10774114     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (4)

1. Patte C, Gerrard M, Auperin A, et al. Results of the randomized international trial FAB LMB 96 for the "intermediate risk" childhood and adolescent B-cell lymphoma: reduced therapy is efficacious. Proc Am Soc Clin Oncol. 2003;22:796.
2. Cairo MS, Gerrard M, Sposto R, et al. Results of a randomized FAB LMB96 international study in children and adolescents with advanced (bone marrow [BM] [B-ALL] and/or CNS B-NHL (large cell [LCL], Burkitt's [BL] and Burkitt-like [BLL]: pts with L3 leukemia/CNS-have an excellent prognosis. Proc Am Soc Clin Oncol. 2003;22:796.
3. Oberlin O, Rey A, Anderson J, et al. Treatment of orbital rhabdomyosarcoma: survival and late effects of treatment-results of an international workshop. J Clin Oncol. 2001;19:197-204.
4. Benk V, Rodary C, Donaldson SS, et al. Parameningeal rhabdomyosarcoma: results of an international workshop. Int J Radiat Oncol Biol Phys. 1996;36:533-540.